Sergio Serafini

484 total citations
11 papers, 393 citations indexed

About

Sergio Serafini is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sergio Serafini has authored 11 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sergio Serafini's work include Histone Deacetylase Inhibitors Research (5 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (3 papers). Sergio Serafini is often cited by papers focused on Histone Deacetylase Inhibitors Research (5 papers), Protein Degradation and Inhibitors (5 papers) and Peptidase Inhibition and Analysis (3 papers). Sergio Serafini collaborates with scholars based in Italy, Switzerland and China. Sergio Serafini's co-authors include Sergio Altamura, Christian Steinkühler, Raffaele De Francesco, Philip Jones, Michael Rowley, Armin Lahm, Paola Gallinari, Alessandra Vitelli, Licia Tomei and Rosa Vitale and has published in prestigious journals such as The EMBO Journal, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Sergio Serafini

11 papers receiving 372 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergio Serafini Italy 11 292 109 72 69 43 11 393
Philippe Neuner Italy 11 475 1.6× 24 0.2× 78 1.1× 66 1.0× 60 1.4× 18 621
Darin Vanderpool United States 8 203 0.7× 72 0.7× 51 0.7× 13 0.2× 146 3.4× 12 395
Liesbet van der Helm Belgium 5 91 0.3× 39 0.4× 36 0.5× 75 1.1× 55 1.3× 6 251
Hock Ben Lim United States 6 127 0.4× 23 0.2× 34 0.5× 119 1.7× 142 3.3× 7 328
Méryl Thomas United States 9 320 1.1× 74 0.7× 62 0.9× 27 0.4× 22 0.5× 10 397
Jimmy P. Xu United States 10 123 0.4× 52 0.5× 32 0.4× 21 0.3× 11 0.3× 13 257
M. E. Marongiu Italy 13 156 0.5× 24 0.2× 133 1.8× 47 0.7× 70 1.6× 36 453
Martine Hamel Canada 11 156 0.5× 15 0.1× 80 1.1× 135 2.0× 79 1.8× 12 423
Peng Zhan China 8 240 0.8× 49 0.4× 161 2.2× 15 0.2× 39 0.9× 9 419
Carlo Boutton Belgium 7 102 0.3× 17 0.2× 69 1.0× 70 1.0× 47 1.1× 9 232

Countries citing papers authored by Sergio Serafini

Since Specialization
Citations

This map shows the geographic impact of Sergio Serafini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Serafini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Serafini more than expected).

Fields of papers citing papers by Sergio Serafini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergio Serafini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Serafini. The network helps show where Sergio Serafini may publish in the future.

Co-authorship network of co-authors of Sergio Serafini

This figure shows the co-authorship network connecting the top 25 collaborators of Sergio Serafini. A scholar is included among the top collaborators of Sergio Serafini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergio Serafini. Sergio Serafini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Didiot, Marie-Cécile, Sergio Serafini, Martin Pfeifer, Frederick J. King, & Christian N. Parker. (2011). Multiplexed Reporter Gene Assays: Monitoring the Cell Viability and the Compound Kinetics on Luciferase Activity. SLAS DISCOVERY. 16(7). 786–793. 14 indexed citations
2.
Ontoria, Jesus M., Alberto Bresciani, Michael Rowley, et al.. (2011). Identification of a series of 4-[3-(quinolin-2-yl)-1,2,4-oxadiazol-5-yl]piperazinyl ureas as potent smoothened antagonist hedgehog pathway inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(18). 5274–5282. 24 indexed citations
3.
Branca, Danila, Federica Ferrigno, Olaf Kinzel, et al.. (2009). Discovery of N-[(1-aryl-1H-indazol-5-yl)methyl]amides derivatives as smoothened antagonists for inhibition of the hedgehog pathway. Bioorganic & Medicinal Chemistry Letters. 19(15). 4191–4195. 17 indexed citations
4.
5.
Scarpelli, Rita, Annalise Di Marco, Federica Ferrigno, et al.. (2008). Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(23). 6078–6082. 17 indexed citations
6.
Pescatore, Giovanna, Olaf Kinzel, Massimiliano Fonsi, et al.. (2008). Optimization of a series of potent and selective ketone histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5528–5532. 11 indexed citations
7.
Jones, Philip, Sergio Altamura, Raffaele De Francesco, et al.. (2008). Probing the elusive catalytic activity of vertebrate class IIa histone deacetylases. Bioorganic & Medicinal Chemistry Letters. 18(6). 1814–1819. 81 indexed citations
8.
Jones, Philip, Sergio Altamura, Prasun K. Chakravarty, et al.. (2006). A series of novel, potent, and selective histone deacetylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(23). 5948–5952. 52 indexed citations
9.
Tomei, Licia, Alessandra Vitelli, Raffaele De Francesco, et al.. (2000). Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence. Journal of General Virology. 81(3). 759–767. 68 indexed citations
10.
Cerretani, Mauro, Laura Di Renzo, Sergio Serafini, et al.. (1999). A High-Throughput Radiometric Assay for Hepatitis C Virus NS3 Protease. Analytical Biochemistry. 266(2). 192–197. 12 indexed citations
11.
Toniatti, Carlo, Andrea Cabibbo, Anna Salvati, et al.. (1996). Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.. The EMBO Journal. 15(11). 2726–2737. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philippe Neuner Breakdown of academic impact, for papers by Darin Vanderpool Breakdown of academic impact, for papers by Liesbet van der Helm Breakdown of academic impact, for papers by Hock Ben Lim Breakdown of academic impact, for papers by Méryl Thomas Breakdown of academic impact, for papers by Jimmy P. Xu Breakdown of academic impact, for papers by M. E. Marongiu Breakdown of academic impact, for papers by Martine Hamel Breakdown of academic impact, for papers by Peng Zhan Breakdown of academic impact, for papers by Carlo Boutton
Rankless by CCL
2026